A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase

Breast Cancer Research and Treatment

Volumn 138, Issue 2, 2013, Pages 633-641

  Hou, Ningqi ^a   Huo, Dezheng ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Breast cancer; Hormone receptors; Incidence; Race; SEER; Subgroup

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREND STUDY; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; ASIAN AMERICANS; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; MIDDLE AGED; OCEANIC ANCESTRY GROUP; SEER PROGRAM; UNITED STATES; YOUNG ADULT;

EID: 84879414298     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2434-0     Document Type: Article

References (25)

1. Jemal A, Ward E, Thun MJ (2007) Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 9(3):R28. doi: 10.1186/bcr1672 (Pubitemid 350214681)
2. Katalinic A, Rawal R (2008) Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 107(3):427-430. doi: 10.1007/s10549-007-9566-z (Pubitemid 351172118)
3. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356(16):1670-1674. doi: 10.1056/NEJMsr070105 (Pubitemid 46631679)
4. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289(24):3243-3253. doi: 10.1001/jama.289.24.3243 (Pubitemid 37430077)
5. Cronin KA, Ravdin PM, Edwards BK (2009) Sustained lower rates of breast cancer in the United States. Breast Cancer Res Treat 117(1):223-224. doi: 10.1007/s10549-008-0226-8
6. Krieger N, Chen JT, Waterman PD (2010) Decline in US breast cancer rates after the Women's Health Initiative: socioeconomic and racial/ethnic differentials. Am J Public Health 100(Suppl 1):S132-S139. doi: 10.2105/AJPH.2009.181628
7. DeSantis C, Howlader N, Cronin KA, Jemal A (2011) Breast cancer incidence rates in US women are no longer declining. Cancer Epidemiol Biomarkers Prev 20(5):733-739. doi: 10.1158/1055-9965.EPI-11-0061
8. Eheman C, Henley SJ, Ballard-Barbash R, Jacobs EJ, Schymura MJ, Noone AM, Pan L, Anderson RN, Fulton JE, Kohler BA, Jemal A, Ward E, Plescia M, Ries LA, Edwards BK (2012) Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 118(9):2338-2366. doi: 10.1002/cncr.27514
9. Anderson WF, Katki HA, Rosenberg PS (2011) Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst 103(18):1397-1402. doi: 10.1093/jnci/djr257
10. SEER-18 Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEERStat Database: Incidence - SEER 18 Regs Research Data, Nov 2011 Sub (1973-2009) < Katrina/Rita Population Adjustment > - Linked To County Attributes - Total U.S., 1969-2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released Apr 2012, based on the Nov 2011 submission
11. White IR, Royston P (2009) Imputing missing covariate values for the Cox model. Stat Med 28(15):1982-1998. doi: 10.1002/sim.3618
12. Van Buuren S, Boshuizen HC, Knook DL (1999) Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 18(6):681-694 (Pubitemid 29126744)
13. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19(3):335-351 (Pubitemid 30070608)
14. Pfeiffer RM, Mitani A, Matsuno RK, Anderson WF (2008) Racial differences in breast cancer trends in the United States (2000-2004). J Natl Cancer Inst 100(10):751-752. doi: 10.1093/jnci/djn112
15. Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, Lacey JV Jr (2012) Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst 104(14):1094-1101. doi: 10.1093/jnci/djs264
16. Nederend J, Duijm LE, Louwman MW, Groenewoud JH, Donkers-van Rossum AB, Voogd AC (2012) Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study. Ann Oncol 23(12):3098-3103. doi: 10.1093/annonc/mds146
17. van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ (2012) Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med 156(9):609-617. doi: 10.1059/0003-4819-156-9-201205010-00002
18. Kirsh VA, Chiarelli AM, Edwards SA, O'Malley FP, Shumak RS, Yaffe MJ, Boyd NF (2011) Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program. J Natl Cancer Inst 103(12):942-950. doi: 10.1093/jnci/djr138
19. Bluekens AM, Holland R, Karssemeijer N, Broeders MJ, den Heeten GJ (2012) Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study. Radiology 265(3):707-714. doi: 10.1148/radiol.12111461
20. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D'Orsi C, Jong R, Rebner M (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353(17):1773-1783. doi: 10.1056/NEJMoa052911 (Pubitemid 41549889)
21. Ryerson AB, Miller JW, Eheman CR, Leadbetter S, White MC (2008) Recent trends in US mammography use from 2000 to 2006: a population-based analysis. Prev Med 47(5):477-482. doi: 10.1016/j.ypmed.2008.06.010
22. Miller JW, King JB, Joseph DA, Richardson LC (2012) Breast cancer screening among adult women - behavioral risk factor surveillance system, United States, 2010. MMWR Morb Mortal Wkly Rep 61(Suppl):46-50
23. Breen N, Gentleman JF, Schiller JS (2011) Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer 117(10):2209-2218. doi: 10.1002/cncr.25679
24. U.S. Preventive Services Task Force (2002) Screening for breast cancer: recommendations and rationale. Ann Intern Med 137(5 Part 1):344-346
25. U.S. Preventive Services Task Force (2009) Screening for breast cancer: US preventive services task force recommendation statement. Ann Intern Med 151(10):716-726. doi: 10.1059/0003-4819-151-10-200911170-00008 W-236